Steven Yatomi Clarke – CEO and Managing Director – Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.
Copyright 2023 – Finance News Network
29 Mar 2021 - Telix Pharmaceuticals Limited (ASX:TLX) Chief Business Officer Dr David Cade talks about the company's clinical programs, including approvals, partnerships and significant value events anticipated in 2021.
03 Feb 2020 - Embark Ventures Managing Partner Michael Curtis provides an update on talks about the company's role as investment manager for MMJ Group Holdings (ASX:MMJ), the Canadian cannabis market and what’s planned for the portfolio.
30 Aug 2023 - icetana Limited (ASX:ICE) Non-Executive Chair Matt Macfarlane discusses his transition from the CEO role, the company's artificial intelligence solution, annual recurring revenue growth, and the recent contract secured with the Sydney Opera House.
09 Jun 2020 - First Graphene Limited (ASX:FGR) Non-Executive Chairman Warwick Grigor talks about graphene-enhanced products, the company's capital raising and its focus on the mining industry.
12 Oct 2022 - icetana (ASX:ICE) CEO and Managing Director Matt Macfarlane discusses revenue growth, the company's strategic placement to Macnica, changes to the share registry and the outlook ahead.